The evolving landscape of the economics of HIV treatment and prevention
- PMID: 22347816
- PMCID: PMC3279512
- DOI: 10.1371/journal.pmed.1001174
The evolving landscape of the economics of HIV treatment and prevention
Abstract
Bohdan Nosyk and Julio Montaner argue that the cost-effectiveness of HAART roll out has been significantly underestimated because economic analyses haven't yet taken into account the beneficial impact of HAART on HIV transmission.
Conflict of interest statement
BN is a Canadian Institutes of Health Research (CIHR) Bisby Fellow, and also supported by a postdoctoral fellowship from the Michael Smith Foundation for Health Research. Since 2011, JSGM has received grants from antiretroviral manufacturers Abbott, Biolytical, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV Healthcare. JSGM is also supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, Province of British Columbia, Canada (2009); by a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR-2010); and through an Avant-Garde Award (No. 1DP1DA026182-01) from the National Institute of Drug Abuse at the US National Institutes of Health (2008–2013). During 2011 to present, JSGM has received support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institute on Drug Abuse, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), Bill & Melinda Gates Foundation, French National Agency for Research on AIDS & Viral Hepatitis (ANRS), and Public Health Agency of Canada.
Similar articles
-
The economic viability of antiretroviral adherence interventions.Am J Med. 2003 Dec 1;115(8):672-3. doi: 10.1016/j.amjmed.2003.09.023. Am J Med. 2003. PMID: 14656623 No abstract available.
-
Lost but not forgotten--the economics of improving patient retention in AIDS treatment programs.PLoS Med. 2009 Oct;6(10):e1000174. doi: 10.1371/journal.pmed.1000174. Epub 2009 Oct 27. PLoS Med. 2009. PMID: 19859529 Free PMC article.
-
Economics of antiretroviral treatment vs. circumcision for HIV prevention.Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21271-6. doi: 10.1073/pnas.1209017110. Epub 2012 Dec 6. Proc Natl Acad Sci U S A. 2012. PMID: 23223563 Free PMC article.
-
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.Lancet. 2006 Aug 5;368(9534):531-6. doi: 10.1016/S0140-6736(06)69162-9. Lancet. 2006. PMID: 16890841 Review. No abstract available.
-
Optimizing HIV treatment programs.Curr Opin HIV AIDS. 2010 May;5(3):232-6. doi: 10.1097/COH.0b013e32833860d3. Curr Opin HIV AIDS. 2010. PMID: 20539079 Review.
Cited by
-
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy.BMC Health Serv Res. 2018 Sep 6;18(1):691. doi: 10.1186/s12913-018-3507-x. BMC Health Serv Res. 2018. PMID: 30189882 Free PMC article.
-
Antiretroviral therapy for refugees and internally displaced persons: a call for equity.PLoS Med. 2014 Jun 10;11(6):e1001643. doi: 10.1371/journal.pmed.1001643. eCollection 2014 Jun. PLoS Med. 2014. PMID: 24915050 Free PMC article.
-
How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV.PLoS One. 2014 Nov 5;9(11):e111956. doi: 10.1371/journal.pone.0111956. eCollection 2014. PLoS One. 2014. PMID: 25372770 Free PMC article.
-
The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings.AIDS Patient Care STDS. 2014 May;28(5):268-73. doi: 10.1089/apc.2013.0356. Epub 2014 Apr 17. AIDS Patient Care STDS. 2014. PMID: 24742299 Free PMC article. Review.
-
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain.Clinicoecon Outcomes Res. 2013 May 23;5:215-21. doi: 10.2147/CEOR.S43662. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23723714 Free PMC article.
References
-
- UNAIDS. UNAIDS report on the global AIDS epidemic 2010. 2010. Available: http://www.unaids.org/globalreport/global_report.htm. Accessed 10 September 2011.
-
- Lomborg B, Piot P. Re-thinking the fight against AIDS. 27 September 2011. Wall Street Journal Online. Available: http://online.wsj.com/article/SB1000142405311190419460457658307125829022.... Accessed 27 September 2011.
-
- Fauci AS. AIDS: Let science inform policy. Science. 2011;333:13. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical